Case Study: Caraco V. Novo Nordisk
On April 17, the United States Supreme Court held that a generic drug manufacturer who is sued for infringement of a method-of-use patent pursuant to the Hatch-Waxman Act may assert a...To view the full article, register now.
Already a subscriber? Click here to view full article